Stephen Bloch, MD

Dr. Stephen Bloch is a highly accomplished professional with a diverse educational background and extensive experience in the medical and business sectors.

He pursued his Doctor of Medicine (MD) in Medicine at the University of Rochester School of Medicine and Dentistry, and furthered his studies with a Diagnostic Radiology Residency and Fellowship at the prestigious Massachusetts General Hospital.

Dr. Bloch also holds an AB in History from Dartmouth College, a Master of Arts (MA) in History and Philosophy of Science and Technology from Harvard University, and completed the Internal Medicine Residency Program at Lenox Hill Hospital.

Throughout his career, he has held prominent leadership positions, having served as Chief Executive Officer at EvolveImmune Therapeutics and Allyx Therapeutics, Inc., Chairman Of the Board at Liquidia Corporation, General Partner at Canaan Partners, and Chief Executive Officer at Radiology Management Sciences.

Additionally, Dr. Bloch has shared his expertise as a consultant at Arthur D. Little, demonstrating a well-rounded professional portfolio in various healthcare and biotechnology organizations.